Teligent Regains Compliance with NASDAQ Listing Requirements
23 June 2020 - 6:15AM
Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New
Jersey-based specialty generic pharmaceutical company, announced
today that it received notice from The NASDAQ Stock Market LLC
(“NASDAQ”) on June 18, 2020 indicating that the Company has
regained compliance with NASDAQ Listing Rule 5450(a)(1), which
requires the Company’s common stock to maintain a minimum bid price
of $1.00 per share. The NASDAQ staff made this determination of
compliance after the closing bid price of the Company’s common
stock was at $1.00 per share or greater for the prior 10
consecutive business days.
NASDAQ had previously notified the Company of its
non-compliance with NASDAQ Listing Rule 5450(a)(1) on June 5, 2019,
following 30 consecutive business days for which the closing bid
price of the Company’s common stock did not meet the $1.00 per
share minimum requirement.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical
company. Our mission is to be a leading player in the specialty
generic prescription drug market. Learn more on our
website www.teligent.com.
Contact: |
Damian FinioTeligent, Inc.(856) 336-9117www.teligent.com |
Teligent (NASDAQ:TLGT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Teligent (NASDAQ:TLGT)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Teligent Inc (NASDAQ): 0 recent articles
More News Articles